Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.

ABSTRACT:

Importance

To promote the identification of women carrying BRCA1/2 variants, the US Preventive Services Task Force recommends that primary care clinicians screen asymptomatic women for an increased risk of carrying a BRCA1/2 variant risk.

Objective

To examine the effects of patient and clinician decision support about BRCA1/2 genetic testing compared with standard education alone.

Design, setting, and participants

This clustered randomized clinical trial was conducted at an academic medical center including 67 clinicians (unit of randomization) and 187 patients. Patient eligibility criteria included women aged 21 to 75 years with no history of breast or ovarian cancer, no prior genetic counseling or testing for hereditary breast and ovarian cancer syndrome (HBOC), and

SUBMITTER: Kukafka R 

PROVIDER: S-EPMC9294997 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature